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A 28-year-old immigrant presented with a 2-week history
of throbbing headache. Contrast-enhanced computed to-
mography (CECT) examination showed multiple brain
abscesses. He is a known defaulter from miliary tubercu-
losis treatment. 18F-FDG PET/CT demonstrated multiple
visually high metabolic activity lesions disseminated in the
brain, thorax, abdomen and pelvis [1]. The maximum
standard uptake values (SUVmax) of these lesions were
substantially > 3.0 and comparable to the uptake of FDG-
avid malignant lesions. These findings demand careful
image interpretation implicating false-positive results [2, 3].
Our case illustrates the usefulness of 18F-FDG PET/CT in
mapping active tuberculous lesions which can be used for
baseline study [4].
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